Retinoblastoma is the most common intraocular malignancy during childhood. It is one of the cancers with a great success story since the life salvage rates have improved drastically over the years. This has been possible due to many advancements in the treatment modalities in this field. However, the prognosis of the disease is not the same in all countries due to disparity in the presentation, availability of treatment, and awareness about the disease.

Retinoblastoma Today, is a unique meeting focusing entirely on the topic of Retinoblastoma. Common case scenarios and recent advances in the treatment modalities will be discussed at this meeting. We will be having case discussions from different parts of the world. This will help us to understand the pattern of retinoblastoma presentation and treatment across the world. This experience will help us to learn from each other and make further advancements in this area.